Biological Data Visualization Market by 3M, Thermo Fisher, Agilent, QIAGEN

The global Biological Data Visualization Market size is expected to reach USD 1.6 billion by 2027, registering a CAGR of 9.6% during the forecast period, according to a new report by Grand View Research, Inc. The magnitude of data explosion in the field of life sciences is one of the key drivers for the market growth.

For instance, in 2019, 11,521 numbers of structures were released in the Protein Data Bank database as compared to 11,190 in 2018. This increase is expected to drive the usage of the analysis and visualization tools by researchers, which will subsequently boost the market growth.

A paradigm shift to data-driven biomedical science has led to the expansion of personalized medicine. It allows the customization of healthcare solutions by tailoring medical treatment for every individual based on their medical history and imaging information. The application of efficient visualizing tools assists the extraction of information from digitalized images and supports personalized care. This factor drives the adoption of these tools for personalized medicine.

Visualization of biological information represents a vital step in life-science research. The incorporation of these tools overcomes the challenges of handling complex data during the biomedical research and further facilitates the understanding of biological processes in cells and organisms. These challenges include information overload, high dimensionality of data, data interconnectivity, and pattern extraction.

Request a free sample copy or view report summary: Biological Data Visualization Market

Biological Data Visualization Market Report Highlights

• The sequencing segment dominated the market in terms of revenue share in 2019 owing to its wide applicability in the understanding of different types of biological datasets
• Rise in the availability ofhigh-throughput genome sequencing solutions and the plummeting cost of sequencing further drives the visualization of sequencing data
• The application of tools for visualizing images of cells and organisms accounted for the largest share in terms of revenue in 2019
• Recent advancements in the high-throughput and imaging techniques, such as cryo-electron microscopy, provide lucrative growth avenues for segment progression
• Large customer base and high compatibility of Windows with all kinds of software is attributing to the larger revenue share of the Windows operating system in 2019
• Pharmaceutical and biotechnology companies are anticipated to grow at a rapid pace in the coming years due to increasing competition in the industry
• Thousands of patents for drugs are registered annually within the pharmaceutical industry. This significantly raises the demand for network visualization in the drug discovery procedures
• A substantial number of research studies based on genomic analysis, cell and organism imaging, molecular modeling, and systems biology has contributed to the dominant revenue share of North America
• Key market players operating in the biological data visualization market include 3M, Thermo Fisher, Agilent, QIAGEN, BD, Carl Zeiss, OLYMPUS CORPORATION, and Oxford Instruments
• Market vendors are involved in several strategic growth initiatives, such as partnerships, novel product developments, and agreements to reinforce their market presence.